Progesterone action on the LHRH and the nigrostriatal dopamine neuronal systems: in vitro and in vivo studies.
D000818:Animals; D003342:Corpus Striatum / Q000187:drug effects*; D000242:Cyclic AMP / Q000502:physiology; D015232:Dinoprostone; D004298:Dopamine / Q000378:metabolism; D004723:Endorphins / Q000502:physiology; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000378:metabolism*; D066298:In Vitro Techniques; D007986:Luteinizing Hormone / Q000378:metabolism; D008297:Male; D008473:Median Eminence / Q000187:drug effects; D009638:Norepinephrine / Q000378:metabolism; D011188:Potassium / Q000494:pharmacology; D011374:Progesterone / Q000494:pharmacology*; D011458:Prostaglandins E / Q000502:physiology; D051381:Rats; D011954:Receptors, Dopamine / Q000187:drug effects*; D013378:Substantia Nigra / Q000187:drug effects*; D001615:beta-Endorphin
D004723:Endorphins; D011458:Prostaglandins E; D011954:Receptors, Dopamine; D007987:Gonadotropin-Releasing Hormone; D011374:Progesterone; D001615:beta-Endorphin; D007986:Luteinizing Hormone; D000242:Cyclic AMP; D015232:Dinoprostone; D011188:Potassium; D004298:Dopamine; D009638:Norepinephrine